German Regulators Decry Lack of Trial Transparency in Look at Stem Cell … – Regulatory Focus
Regulatory Focus |
German Regulators Decry Lack of Trial Transparency in Look at Stem Cell …
Regulatory Focus The German Institute for Quality and Efficiency in Health Care (IQWiG) has found recent clinical data on the use of stem cell transplantation to treat multiple myeloma—a rare and deadly form of cancer—to be inconclusive. |
